Generic Versions of Levofloxacin Approved

Antibiotic prescribed for infections of sinuses, kidneys or bladder

MONDAY, June 20 (HealthDay News) -- The first generic versions of levofloxacin, prescribed under the brand name Levaquin, have been approved by the U.S. Food and Drug Administration.

The antibiotic is sanctioned for infections of the skin, sinuses, kidneys, bladder or prostate, as well as certain strains of bacterial bronchitis or pneumonia, the agency said in a news release.

The generic versions, licensed to be produced by 12 manufacturers, is chemically equivalent to the brand-name drug. It belongs to a class of drugs called fluoroquinolones, which have a boxed label warning for increased risk of tendonitis and tendon rupture. The risk is higher among people 60 and older, among people who take corticosteroid drugs, and among people who have had kidney, heart or lung transplants, the FDA said.

More information

To learn more about this drug, visit the U.S. National Library of Medicine.

Scott Roberts

Related Articles

Learn More About Sharp
Sharp HealthCare is San Diego's health care leader with seven hospitals, two medical groups and a health plan. Learn more about our San Diego hospitals, choose a Sharp-affiliated San Diego doctor or browse our comprehensive medical services.

Health News is provided as a service to Sharp Web site users by HealthDay. Sharp HealthCare nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please read the Terms of Use for more information.